GRMN:NYSEGarmin Ltd. Analysis
Data as of 2026-03-10 - not real-time
$238.61
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Garmin posted a robust 17% revenue growth YoY, with healthy gross (58.7%) and operating margins (28.9%). Earnings per share jumped to $8.59 and the forward estimate is $10.17, while cash balances exceed $2.7B and debt is modest, supporting a 40% payout ratio and a dividend yield of 1.73%. The stock trades at $238.61, just above the 20‑day SMA ($237.78) and below the 50‑day SMA, with an RSI of 55 and a bearish MACD histogram, indicating a neutral‑to‑slightly‑downward short‑term momentum. However, the DCF fair value of $126 is far below the current price, yet the PE ratio (27.8) is well under the industry average (36.7) and analysts’ median target of $258 suggests ~9% upside.
Risk is heightened by a 30‑day volatility of over 40% and a beta around 1.2, while volume trends are weakening, pointing to liquidity concerns. Nonetheless, the company’s diversified exposure across fitness, aviation, marine and automotive segments, low regulatory headwinds, and strong cash flow make the dividend sustainable. The overall picture favors a hold for the immediate term but a buy outlook over medium to long horizons as earnings momentum and dividend growth continue.
Risk is heightened by a 30‑day volatility of over 40% and a beta around 1.2, while volume trends are weakening, pointing to liquidity concerns. Nonetheless, the company’s diversified exposure across fitness, aviation, marine and automotive segments, low regulatory headwinds, and strong cash flow make the dividend sustainable. The overall picture favors a hold for the immediate term but a buy outlook over medium to long horizons as earnings momentum and dividend growth continue.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD histogram and decreasing volume
- Price hovering near 20‑day SMA with neutral RSI
- Limited upside to immediate resistance at $256
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong 17% revenue growth and expanding margins
- Analyst median target price of $258 indicating ~9% upside
- Sustainable dividend with low payout ratio and solid cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified product portfolio across high‑growth segments (fitness, aviation, marine)
- Robust balance sheet with ample cash and low leverage
- Consistent earnings expansion and potential dividend increases
Key Metrics & Analysis
Financial Health
Revenue Growth16.60%
Profit Margin22.96%
P/E Ratio27.8
ROE19.78%
ROA11.37%
Debt/Equity2.18
P/B Ratio5.1
Op. Cash Flow$1.6B
Free Cash Flow$790.9M
Industry P/E36.7
Technical Analysis
TrendNeutral
RSI55.0
Support$201.19
Resistance$256.80
MA 20$237.78
MA 50$218.97
MA 200$220.62
MACDBearish
VolumeDecreasing
Fear & Greed Index76.84
Valuation
Fair Value$126.46
Target Price$260.25
Upside/Downside9.07%
GradeFair
TypeBlend
Dividend Yield1.73%
Risk Assessment
Beta1.22
Volatility41.49%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.